Forsyth Barr highlights 'hidden gem' and growth opportunity at Ebos

Forsyth Barr highlights 'hidden gem' and growth opportunity at Ebos
Ebos has room to grow. (Image: Ebos)
Rebecca Howard
Ebos Group’s Australian Biotechnologies is a "hidden gem" while Transmedic offers a solid platform for future growth, Forsyth Barr analysts said.The two businesses represent about 15% of the group’s FY25 earnings before interest, taxes, depreciation and amortisation and “have higher organic growth than the group over the medium term”, Matt Montgomerie and Benjamin Crozier said.Both were initially acquired as part of its A$1.16 billion (NZ$1.25b)  LifeHealthcare acquisition, which was completed in May 2022....

More Markets

NZX falls as Synlait and Mainfreight take hits
Markets Market Close

NZX falls as Synlait and Mainfreight take hits

Market reacts strongly to news of "challenges" at Synlait's Dunsandel plant.

Tom Raynel 30 Jul 2025
'Slow and disappointing' start to the year for Mainfreight
Markets

'Slow and disappointing' start to the year for Mainfreight

The freight and logistics firm said profits were down across its three main divisions.

Staff reporters 30 Jul 2025
Ryman toils to rebuild shareholder confidence
Property

Ryman toils to rebuild shareholder confidence

"When is the total board going to resign?" asked one shareholder.

Gregor Thompson 30 Jul 2025
Synlait shares slump 11% even as outlook brightens
Primary Sector

Synlait shares slump 11% even as outlook brightens

The market is disappointed about manufacturing challenges. 

Rebecca Howard 30 Jul 2025